cGMPnow specializes in providing comprehensive solutions for the manufacturing of next-generation therapeutic products, focusing on Good Manufacturing Practice (GMP) systems. Their offerings include GxP manufacturing and quality control laboratory equipment, computerized systems, and services for commissioning and qualification. By employing a unique project delivery methodology, cGMPnow aims to expedite the market introduction of new therapies, ensuring that clients can initiate production operations more swiftly. Their expertise encompasses the development of cGxP specifications, facility conceptual design, and detailed architecture, all tailored to meet the stringent requirements of the biopharmaceutical industry.

In addition to equipment and systems, cGMPnow also provides GMP real estate support through strategic partnerships, facilitating site selection and facility design/build options. Their end-to-end solutions are designed to address common industry challenges, such as the disconnect between facility design and GxP system requirements. By focusing on GxP readiness from the outset, cGMPnow helps clients navigate the complexities of regulatory compliance and project execution, ultimately accelerating the delivery of life-saving products to patients.

United States

cGMPnow accelerates Gene & Cell Therapy products to patients by providing GMP Manufacturing & QC Laboratory Equipment, Automation & Controls (IT/OT), Commissioning & Qualification, and Procurement services using project-dedicated expert resources.

cGMPnow

Company Details